侵袭性霉菌感染非随机比较效果研究的方法学质量与偏倚风险:系统综述
该系统综述纳入2003至2024年发表的117项评估曲霉病、毛霉病、镰刀菌病等侵袭性霉菌感染干预措施的非随机比较效果研究。结果显示112项(96%)存在至少一个时间点错位,140个可评估问题中116个(83%)易发生永恒时间偏倚,仅1项研究同时避免了时间点错位且未纳入基线后变量进行混杂调整。
要点
- 侵袭性霉菌感染的非随机比较效果研究普遍存在时间点错位,96%的研究至少有一个时间点错位。
- 83%的可评估比较效果问题易发生永恒时间偏倚,34%易发生基线后 eligibility 导致的选择偏倚。
- 仅1项研究同时避免了时间点错位并采用不包含基线后变量的混杂调整方法。
核心结论
- 侵袭性霉菌感染的非随机比较效果研究普遍存在结构易感性偏倚,不限于罕见霉菌,需改进未来研究设计。
研究设计与样本
- 系统综述纳入2003至2024年发表的117项非随机比较效果研究,评估曲霉病、毛霉病、镰刀菌病、赛多孢子菌病、Lomentospora感染或暗色丝孢霉病的干预措施。
主要发现
- 117项研究中112项(96%)存在至少一个时间点错位。
- 140个可评估比较效果问题中,116个(83%)易发生永恒时间偏倚,47个(34%)易发生基线后 eligibility 导致的选择偏倚,13个(9%)易发生现患用户偏倚。
- 117项研究中76项(65%)调整了混杂,但变量选择常依赖统计方法,其中26项(34%)纳入了基线后变量。
- 仅1项研究避免了时间点错位且混杂调整未纳入基线后变量。
关键数值与推荐
- 时间点错位:112/117项研究(96%)至少一个时间点错位。
- 永恒时间偏倚:116/140个可评估问题(83%)易感。
- 基线后 eligibility 选择偏倚:47/140个问题(34%)易感。
- 现患用户偏倚:13/140个问题(9%)易感。
- 混杂调整:76/117项研究(65%)调整混杂,其中26/76项(34%)纳入基线后变量。
临床怎么用
- 解读侵袭性霉菌感染的非随机比较效果研究时,应关注时间点错位、永恒时间偏倚及基线后变量调整带来的偏倚风险。
- 设计未来非随机比较效果研究时,可参考本文提出的结构偏倚评估框架,避免时间点错位并谨慎选择混杂调整变量。
局限性
- 本文未明确报告所纳入研究的其他方法学局限性细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many treatment recommendations for invasive mould infections, particularly those caused by rare moulds, rely on non-randomised comparative effectiveness research (CER), which is vulnerable to design and analytical limitations that can bias effect estimates. We systematically reviewed 117 non-randomised studies evaluating interventions for aspergillosis, mucormycosis, fusariosis, scedosporiosis, lomentosporiosis, or phaeohyphomycosis published from 2003 to 2024. We assessed structural susceptibility to bias from misalignment of eligibility, treatment assignment, and start of follow-up, and approaches to confounding adjustment. 112 (96%) of 117 studies had at least one timepoint misalignment. Of 140 evaluable CER questions, 116 (83%) were susceptible to immortal time bias, 47 (34%) to selection bias from post-baseline eligibility, and 13 (9%) to prevalent-user bias. 76 (65%) of 117 studies adjusted for confounding but variable selection often relied on statistical methods and 26 (34%) of those 76 studies included post-baseline variables. This structural susceptibility to bias was present across all pathogen groups, not only rare moulds. Only one study avoided timepoint misalignment and accounted for confounding without incorporating post-baseline variables. These findings could provide a framework to improve the design of future non-randomised CER studies.
引用
- Paccoud O, Yaacoub S, Marie J, et al. Methodological quality and risk of bias in non-randomised comparative effectiveness studies of invasive mould infections: a systematic review. Lancet Infect Dis. 2026. PMID: 42805225. doi:10.1016/S1473-3099(26)00380-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。